<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Specific cytogenetic alterations in t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> are associated with different chemotherapeutic agents, such as loss of chromosomal material from #5 and #7 with alkylators </plain></SENT>
<SENT sid="1" pm="."><plain>No data have been published on secondary <z:hpo ids='HP_0001909'>leukemias</z:hpo> following the <z:chebi fb="0" ids="36064">taxane</z:chebi> docetaxel </plain></SENT>
<SENT sid="2" pm="."><plain>We report a patient, who being in long-term remission after docetaxel-based induction chemotherapy with docetaxel and <z:chebi fb="2" ids="31355">carboplatin</z:chebi>, surgery and adjuvant radiotherapy for <z:e sem="disease" ids="C0278984" disease_type="Neoplastic Process" abbrv="">non-small cell lung cancer stage IIIB</z:e>, developed a t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and subsequently a t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> 40 months after start of therapy </plain></SENT>
<SENT sid="3" pm="."><plain>The t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> was characterised by a complex aberrant karyotype including <z:mp ids='MP_0004026'>monosomy</z:mp> #13 and partial <z:mp ids='MP_0004026'>monosomies</z:mp> of #5 and #7 </plain></SENT>
<SENT sid="4" pm="."><plain>This is the first report in the literature of t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> after docetaxel chemo-radiotherapy, implicating a possible association of docetaxel with alkylator type t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The case will be discussed in the context of a review of the current literature </plain></SENT>
</text></document>